Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of FS Grifols in Pediatric Surgery
NCT03461406Phase 3Completed
- Sponsor
- Grifols
- Start
- Jan 2019
- Primary completion
- Apr 2022
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of VISTASEAL in Not applicable, sponsored by Grifols. Started Jan 2019; status: completed.
02
Drugs
VISTASEAL
03
Conditions
Not applicable
Beyond the preview
Go deeper on NCT03461406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03461406.